Free Trial

Enzo Biochem (ENZ) News Today

$1.16
0.00 (0.00%)
(As of 02:25 PM ET)
Enzo Biochem logo with Medical background
Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Declines By 6.9%
Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 560,500 shares, a drop of 6.9% from the May 31st total of 602,300 shares. Currently, 1.6% of the shares of the stock are sold short. Based on an average daily volume of 114,700 shares, the days-to-cover ratio is presently 4.9 days.
Enzo Biochem, Inc. (ENZ)
Enzo Biochem, Inc. (NYSE:ENZ) Sees Large Decrease in Short Interest
Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 29th, there was short interest totalling 715,400 shares, a decrease of 9.8% from the February 14th total of 792,900 shares. Approximately 2.1% of the company's shares are sold short. Based on an average daily trading volume, of 113,500 shares, the short-interest ratio is presently 6.3 days.
Enzo Biochem: Fiscal Q2 Earnings Snapshot
Enzo Biochem, Inc. (NYSE:ENZ) Short Interest Update
Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 792,900 shares, a growth of 5.1% from the January 31st total of 754,700 shares. Based on an average trading volume of 112,600 shares, the days-to-cover ratio is presently 7.0 days. Currently, 2.3% of the company's shares are short sold.
Enzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.38
Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above Two Hundred Day Moving Average of $1.38
Enzo Biochem, Inc.
Jim Simons Trims Stake in Enzo Biochem Inc
Enzo Biochem Appoints New CEO and CFO
Enzo Biochem Inc (EZB.SG)
Enzo Biochem Inc ENZ
Enzo Biochem CEO Hamid Erfanian Resigns After Two Years
Enzo Biochem (NYSE: ENZ)
Enzo Biochem cuts price for labs assets to Labcorp
Short Volatility Alert: Enzo Biochem Inc
Enzo Biochem reports Q3 results
Get Enzo Biochem News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter.

New Biden Law just went into effect (Ad)

Congress has allocated $400 billion to support this law, and is considering approving billions more by the end of this year. And leaders from both sides of the aisle just issued a joint statement calling the signing of this law “a momentous day” for America – and critical to national security.

You can view his briefing by clicking here.

ENZ Media Mentions By Week

ENZ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENZ
News Sentiment

-1.00

0.93

Average
Medical
News Sentiment

ENZ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENZ Articles
This Week

1

0

ENZ Articles
Average Week

Get Enzo Biochem News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:ENZ) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners